SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-375638
Filing Date
2015-11-12
Accepted
2015-11-12 16:06:08
Documents
1
Period of Report
2015-11-10
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d77840d8k.htm 8-K 13302
  Complete submission text file 0001193125-15-375638.txt   14397
Mailing Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Filer) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36070 | Film No.: 151224819
SIC: 2834 Pharmaceutical Preparations